Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cynara scolymus extract for type 2 diabetes
NCT04233658Phase 3Unknown
- Start
- May 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of artichoke leaf extract in type 2 diabetes mellitus (T2DM). Primary endpoint: Hemoglobin A1c at 12 weeks. Status: unknown.
02
Drugs
artichoke leaf extract
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04233658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233658.